Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis

The effect of the calcimimetic cinacalcet on cardiovascular disease in patients undergoing hemodialysis with secondary hyperparathyroidism was assessed in the Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events trial. This was the largest (in size) and longest (in duration)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin J Am Soc Nephrol
Autores principales: Parfrey, Patrick S., Block, Geoffrey A., Correa-Rotter, Ricardo, Drüeke, Tilman B., Floege, Jürgen, Herzog, Charles A., London, Gerard M., Mahaffey, Kenneth W., Moe, Sharon M., Wheeler, David C., Chertow, Glenn M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2016
Materias:
Special Feature
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791832/
https://ncbi.nlm.nih.gov/pubmed/26614406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06370615
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares